FY2026 EPS Estimates for CME Group Raised by Zacks Research

CME Group Inc. (NASDAQ:CME) – Equities research analysts at Zacks Research boosted their FY2026 EPS estimates for shares of CME Group in a research note issued to investors on Tuesday, February 4th. Zacks Research analyst T. De now forecasts that the financial services provider will earn $10.80 per share for the year, up from their prior estimate of $10.74. The consensus estimate for CME Group’s current full-year earnings is $10.18 per share. Zacks Research also issued estimates for CME Group’s Q4 2026 earnings at $2.95 EPS.

CME has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and cut their target price for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Keefe, Bruyette & Woods dropped their price objective on CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a research note on Monday, January 13th. Morgan Stanley raised their target price on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research report on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $229.27.

CME Group Stock Performance

Shares of CME opened at $241.64 on Thursday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 1 year low of $190.70 and a 1 year high of $249.02. The firm has a fifty day moving average of $235.20 and a 200-day moving average of $223.49. The company has a market cap of $87.08 billion, a price-to-earnings ratio of 25.41, a price-to-earnings-growth ratio of 5.37 and a beta of 0.57.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Plato Investment Management Ltd increased its position in CME Group by 3.1% in the 4th quarter. Plato Investment Management Ltd now owns 15,860 shares of the financial services provider’s stock worth $3,697,000 after buying an additional 470 shares during the period. SBI Securities Co. Ltd. acquired a new position in CME Group during the 4th quarter valued at $390,000. Jones Financial Companies Lllp boosted its holdings in CME Group by 45.0% in the 4th quarter. Jones Financial Companies Lllp now owns 4,575 shares of the financial services provider’s stock valued at $1,062,000 after purchasing an additional 1,419 shares during the period. Modera Wealth Management LLC grew its position in CME Group by 2.3% in the 4th quarter. Modera Wealth Management LLC now owns 4,817 shares of the financial services provider’s stock worth $1,119,000 after purchasing an additional 110 shares during the last quarter. Finally, SRS Capital Advisors Inc. increased its holdings in shares of CME Group by 7,056.5% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,646 shares of the financial services provider’s stock worth $382,000 after purchasing an additional 1,623 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Increases Dividend

The company also recently announced a dividend, which was paid on Thursday, January 16th. Investors of record on Friday, December 27th were paid a $5.80 dividend. The ex-dividend date of this dividend was Friday, December 27th. This is a positive change from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group declared that its Board of Directors has approved a stock repurchase program on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.